← Back to All Filings

OHI Grants CAO Equity Award; Potential 4.88% Dilution Impact

High SignificanceJanuary 15, 2026 at 11:31:56 PM UTC

OMEGA HEALTHCARE INVESTORS INC

$OHI4CIK: 0000888491

Subscribe to track OHI

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

OHI Grants CAO Equity Award; Potential 4.88% Dilution Impact

Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026/01/15 Significance: High

Insider: Ballew Neal Title: CHIEF ACCOUNTING OFFICER | Relationship: Officer

Transaction: • Type: Award/Grant • Shares: 14,401 • Price: $0.00 • Value: $0 • Owned After: 124,678

Key Insight: The grant of 14,401 units represents a potential 4.88% dilution to shares outstanding based on provided market data, a highly significant figure.

Market Context: This is a standard equity compensation grant, but its size relative to the provided shares outstanding figure is exceptionally large, warranting shareholder attention regarding dilution.

Comprehensive Analysis

SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: The Chief Accounting Officer received an equity grant of Profits Interest Units which, based on provided market data, represents a potential 4.88% dilution to total shares outstanding.
  • Market Impact: Neutral in the short term as it's a non-cash grant, but the potential dilution is a significant long-term consideration for shareholders.

Company Information

FieldValue
CompanyOMEGA HEALTHCARE INVESTORS INC
Ticker SymbolOHI
CIK0000888491
IndustryREAL ESTATE INVESTMENT TRUSTS [6798]

Insider Information

FieldValue
NameBallew Neal
CIK0001824484
Title/PositionCHIEF ACCOUNTING OFFICER
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-01-13
Transaction CodeA
Security TypeProfits Interest Units
Shares Involved14,401
Price Per Share$0.00
Total Value$0
Shares Owned After124,678
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted14,401
% of Shares Outstanding4.88%
Post-Transaction Ownership124,678 shares (42.26% of outstanding)
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: Omega Healthcare is a large-cap REIT with a $12.99 billion market capitalization. The grant's value is $0, making it immaterial from a value perspective.
  • Ownership Concentration: Post-transaction, the CAO holds derivative securities convertible into 124,678 shares, representing an unusually high 42.26% of the stated shares outstanding. This level of ownership for a non-founding officer is exceptionally high and suggests an anomaly in the provided shares outstanding data.
  • Dilution Impact: The 14,401 units granted represent a potential 4.88% dilution to the 295,000 shares outstanding. This is a very high level of dilution from a single grant to one executive, far exceeding typical compensation practices.
  • Transaction Significance: The significance is rated 'High' not due to the dollar value, but due to the extreme potential dilution (4.88%) relative to the provided shares outstanding figure. This surpasses the 0.5% threshold for high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Equity grants are a common form of executive compensation and do not signal an insider's immediate market outlook. The primary impact is potential long-term dilution upon vesting and conversion.

Volume & Sentiment

  • Expected Volume Impact: None. This is not an open market trade and does not directly impact trading volume.
  • Sentiment Indicator: Neutral. The grant aligns executive and shareholder interests but the high potential dilution is a countervailing factor.

Investment Insights

Positive Market Indicators

  • The grant aligns the executive's interests with long-term shareholder value, as the value of the units is tied to the company's stock performance.

Risk Factors

  • The potential dilution of 4.88% from a single grant is a major red flag for shareholders.
  • The CAO's post-transaction potential ownership of over 42% of shares outstanding represents a significant concentration of control, which is highly unusual.

Key Takeaways

  1. A grant of 14,401 Profits Interest Units was awarded to the Chief Accounting Officer as part of a compensation plan.
  2. The transaction has a $0 value but represents a potential 4.88% dilution based on the provided shares outstanding data, making it highly significant.
  3. The insider's total potential holdings now represent over 42% of shares outstanding, an extremely high and noteworthy concentration.

Additional Context

Special Circumstances

  • The grant consists of Profits Interest Units (PIUs), which convert to OP Units. Each OP Unit is redeemable for one share of OHI common stock.
  • The units are subject to a three-year cliff vesting schedule, vesting on December 31, 2028, contingent on continued employment.
Topics:#SECFiling#InsiderTrading#OHI#OmegaHealthcare#Form4#EquityGrant#HighSignificance#StockMarket#REIT#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.